Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

BACKGROUND: There is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy and safety of pioglitazone or glimepiride when added to metformin plus alogl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Metab J
Autori principali: Kim, Jeong Mi, Kim, Sang Soo, Kim, Jong Ho, Kim, Mi Kyung, Kim, Tae Nyun, Lee, Soon Hee, Lee, Chang Won, Park, Ja Young, Kim, Eun Sook, Lee, Kwang Jae, Choi, Young Sik, Kim, Duk Kyu, Kim, In Joo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Diabetes Association 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043969/
https://ncbi.nlm.nih.gov/pubmed/31339011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2018.0274
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi